Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

Lambros Kordelas, Vera Rebmann, Anna‐Kristin Ludwig, Stefan Radtke, Johannes Ruesing, Thorsten Roland Doeppner, Matthias Epple, Patrick Horn, Dietrich Wilhelm Beelen, Bernd Giebel

📖 Leukemia → 📅 2014-01-21 🔗 DOI: 10.1038/leu.2014.41
View Journal Profile → View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

🔬 Related Research Papers

Leukemia

Mutations and prognosis in primary myelofibrosis

Alessandro Maria Vannucchi, T L Lasho et al. 2013-04-26 · Read paper → Leukemia

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

Tomáš Kalina, Juan A Flores-Montero et al. 2012-09-01 · Read paper → Leukemia

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Antonia Lopez‐Girona, Derek Mendy et al. 2012-05-03 · Read paper → Leukemia

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

Angela A. Dispenzieri, Robert A. Kyle et al. 2008-11-20 · Read paper → Leukemia

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

E Liu, Yijiu Tong et al. 2017-07-20 · Read paper → Leukemia

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

Antonio Pierangelo Palumbo, S. Vincent Rajkumar et al. 2007-12-20 · Read paper → Leukemia

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Andreas Hochhaus, S G O'Brien et al. 2009-03-12 · Read paper → Leukemia

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Andreas Hochhaus, Giuseppe Nicola Saglio et al. 2016-02-03 · Read paper → Leukemia

Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

Daniel Sommermeyer, Michael Hudecek et al. 2015-09-15 · Read paper → Leukemia

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

Rafaël Fonseca, Peter Leif Bergsagel et al. 2009-10-01 · Read paper → Leukemia

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Robert A. Kyle, Brian G.M. Durie et al. 2010-04-22 · Read paper → Leukemia

Clinical use of lentiviral vectors

Michael C. Milone, Una O’Doherty 2018-03-22 · Read paper →